Birdwatch Note
2023-03-06 07:11:20 UTC - NOT_MISLEADING
Ivermectin: “one of the greatest health interventions of the past 50 years” - 2008 https://www.sciencedirect.com/science/article/abs/pii/S0924857907004451 “inhibits the replication of SARS-CoV-2” https://www.sciencedirect.com/science/article/pii/S0166354220302011 “can prevent the entry…cell nucleus of the viral RNA” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415509/ “has widely proved its efficacy” Entered Human med in 1987 https://www.ingentaconnect.com/content/ben/cpb/2012/00000013/00000006/art00029 “Billions of people” https://www.jstage.jst.go.jp/article/pjab/87/2/87_2_13/_article/-char/ja/
Written by 6CD607A8C1C88CC16103F55735E76226F5130CFB4E167EAF333B78EC0AD327B0
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632547243621244929
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1632639987463364608
- noteId - 1632639987463364608
- participantId - 6CD607A8C1C88CC16103F55735E76226F5130CFB4E167EAF333B78EC0AD327B0
- noteAuthorParticipantId -
- createdAtMillis - 1678086680652
- tweetId - 1632547243621244929
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin: “one of the greatest health interventions of the past 50 years” - 2008 https://www.sciencedirect.com/science/article/abs/pii/S0924857907004451 “inhibits the replication of SARS-CoV-2” https://www.sciencedirect.com/science/article/pii/S0166354220302011 “can prevent the entry…cell nucleus of the viral RNA” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415509/ “has widely proved its efficacy” Entered Human med in 1987 https://www.ingentaconnect.com/content/ben/cpb/2012/00000013/00000006/art00029 “Billions of people” https://www.jstage.jst.go.jp/article/pjab/87/2/87_2_13/_article/-char/ja/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-06 07:11:20 UTC (1678086680652) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-07 02:11:29 UTC (1678155089929) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-06 16:30:26 -0600 | 07618372108E8FBA8439DE6979ED24BBCB38FE3AD0A1C3F447F6F35B4518DE52 | Rating Details |
| 2023-03-06 13:29:51 -0600 | 0BD4990BF3255997269B09B79D8F410C961E941E8728A047A9F5A3FF779F297B | Rating Details |
| 2023-03-06 06:28:42 -0600 | 0D476FB8162A0B894FADC488B9348FFA9313C980B22262F5BC4C4D30F5AA0BC0 | Rating Details |
| 2023-03-06 01:17:07 -0600 | 129685E778F56A48B6181D6701778A9D62B140336F6ED6669651874F947521FE | Rating Details |
| 2023-03-06 01:46:51 -0600 | 129FB080EBA0E6965C70514589DF39FB4D07FCE432589247BE11B1A92015B5B3 | Rating Details |
| 2023-03-06 10:47:19 -0600 | 2425899C10B7F1EBDCBC74B78BC706A6C13CF591FA38668E355D38E05C6D4611 | Rating Details |
| 2023-03-06 05:59:19 -0600 | 2A4169EE19A8A01657FC32ACA31E49627C4645D25E9BB4924CCFEEF066D6E9DD | Rating Details |
| 2023-03-06 08:50:32 -0600 | 34BC1E89C4723C2FD1C55D5F18AA5914BF41C2C20256EDDC887AAF53C41280D7 | Rating Details |
| 2023-03-06 21:05:58 -0600 | 3F9C6BC33A055DDD557A3C2A0D1F7224D73DA767CBD3FAA473F5640A1804CDE1 | Rating Details |
| 2023-03-06 17:25:34 -0600 | 4AED698DA1A72D41B593D8FBF757093E165686BC7C603307D38D67D811EB528C | Rating Details |
| 2023-03-06 01:54:20 -0600 | 5B7965F7C438209394315BD52BAE5D1D35C20AB8C33BEF95E763233061A395C9 | Rating Details |
| 2023-03-06 08:56:04 -0600 | 6AD45ED1365F463DBC10F60EA6B726B21E04F8E142AAE8CB23D594DD2CC312D6 | Rating Details |
| 2023-03-08 08:26:26 -0600 | 6D726319A4D8C972AAFB7B0A9F17D799D0F2BA4003BFDF57F7F8D6A2D8477C4C | Rating Details |
| 2023-03-06 12:42:48 -0600 | 6EFCEEF8B2FD28B46A0AC920CAB617AAFD94E40F41CBB21B3427B60CBC26799A | Rating Details |
| 2023-03-06 03:13:22 -0600 | 71A8D089BB7143D7CFA04A0D7EEF5C32B3B2901386875FDE172BA7A711F2ADB9 | Rating Details |
| 2023-03-06 07:47:34 -0600 | 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 | Rating Details |
| 2023-03-06 13:37:34 -0600 | 7B21754FD69D11EC635B7D0F5C8BB9199F9932702310DB6A5D1ABD92B4FF9462 | Rating Details |
| 2023-03-06 02:43:01 -0600 | 7C0401A71B2DE9724F0DFB55AC5C892BA941C306461D79174CB04F461A81DA56 | Rating Details |
| 2023-03-06 01:17:06 -0600 | 8002B0935053D287603AA6116D4D05CC9DD4240339F108E15F0354140E6DDD4F | Rating Details |
| 2023-03-06 20:43:50 -0600 | 833B4E6289EB447D755F4C2C685565BCD73BA864A84CD9BC3D1B74F0E87ADDB6 | Rating Details |
| 2023-03-06 03:15:58 -0600 | 83FEF76206F4DC8CD9906D9FC71A16E4A82DEDD7EE9EA563D7514F3A82611DA8 | Rating Details |
| 2023-03-06 04:36:45 -0600 | 92E293F56399BE843C7477FBBE4E556A7FF6D3698387C3CB37720C532C03C714 | Rating Details |
| 2023-03-06 02:24:26 -0600 | 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 | Rating Details |
| 2023-03-06 04:43:58 -0600 | AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 | Rating Details |
| 2023-03-06 06:34:57 -0600 | B30C49543C7930381E699C69D5674B291D442BCAD367E679119A96A11CC39FDE | Rating Details |
| 2023-03-06 05:55:41 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
| 2023-03-06 10:57:27 -0600 | BA155A6C7276590184E644B831C87BC038B66A941EDF53B0A3521AC8AB8A6DF0 | Rating Details |
| 2023-03-06 09:07:35 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-03-06 02:27:03 -0600 | C8AD4B40628824B6C5790A9631BDBF0E9B3BEF0D0BEDCDED0361EE04827DD458 | Rating Details |
| 2023-03-06 02:13:47 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
| 2023-03-06 01:33:23 -0600 | CE1E67B1FEB9937B7C6D47043A93A78DEDF0B169BBA3B6DFC46DF275D11557E3 | Rating Details |
| 2023-03-06 01:17:10 -0600 | CE2DE647C2D2D1EE3738900B91EB4094D8F06FEA3FCF4D00EFC4D49B276FEC24 | Rating Details |
| 2023-03-06 06:33:02 -0600 | E12FAE48FEB7596F4B0B7805461337A216695A1136840F9A8A1FA4EB27E9B89A | Rating Details |
| 2023-03-06 16:39:48 -0600 | E24487233FBB323097BC45A9E137296A05633D9329BD346B328C78ED070D6570 | Rating Details |
| 2023-03-06 09:29:29 -0600 | EC2E51AE8C64AE6C0C58E504DFB75E133ECF8F5D0FAC60A72EFC1A51DC264969 | Rating Details |
| 2023-03-06 08:55:56 -0600 | EFC16F5BFF6D5F1B7735B5BDD3B212675346B5048F23B96F9B14DE9DFCAC749A | Rating Details |
| 2023-03-06 01:54:15 -0600 | F7E1BEEDF9E902801B5DA5B285FEDC143B273DD031F0B76CE601E81482F0C2EB | Rating Details |
| 2023-03-06 02:29:17 -0600 | FD5EE4582645F55BDD6FE532405C3E5432B90B7EB9694B61F2FAFC76D2302567 | Rating Details |
| 2023-03-14 13:00:44 -0500 | Rating Details | |
| 2023-03-14 02:29:24 -0500 | Rating Details | |
| 2023-03-13 15:02:01 -0500 | Rating Details | |
| 2023-03-15 00:25:19 -0500 | Rating Details | |
| 2023-03-14 23:37:13 -0500 | Rating Details | |
| 2023-03-14 23:11:25 -0500 | Rating Details | |
| 2023-03-14 22:21:50 -0500 | Rating Details | |
| 2023-03-16 11:46:33 -0500 | Rating Details | |
| 2023-03-17 09:15:04 -0500 | Rating Details | |
| 2023-03-06 02:13:47 -0600 | Rating Details | |
| 2023-03-06 06:28:42 -0600 | Rating Details | |
| 2023-03-06 10:47:19 -0600 | Rating Details | |
| 2023-03-06 08:55:56 -0600 | Rating Details | |
| 2023-03-06 03:13:22 -0600 | Rating Details | |
| 2023-03-06 13:29:51 -0600 | Rating Details | |
| 2023-03-06 01:54:20 -0600 | Rating Details | |
| 2023-03-06 01:46:51 -0600 | Rating Details | |
| 2023-03-14 22:21:50 -0500 | Rating Details | |
| 2023-03-15 00:25:19 -0500 | Rating Details | |
| 2023-03-06 01:54:15 -0600 | Rating Details | |
| 2023-03-06 05:59:19 -0600 | Rating Details | |
| 2023-03-06 16:30:26 -0600 | Rating Details | |
| 2023-03-06 21:05:58 -0600 | Rating Details | |
| 2023-03-06 06:33:02 -0600 | Rating Details | |
| 2023-03-06 05:55:41 -0600 | Rating Details | |
| 2023-03-06 01:33:23 -0600 | Rating Details | |
| 2023-03-06 09:07:35 -0600 | Rating Details | |
| 2023-03-13 15:02:01 -0500 | Rating Details | |
| 2023-03-14 13:00:44 -0500 | Rating Details | |
| 2023-03-06 13:37:34 -0600 | Rating Details | |
| 2023-03-06 09:29:29 -0600 | Rating Details | |
| 2023-03-06 08:50:32 -0600 | Rating Details | |
| 2023-03-06 17:25:34 -0600 | Rating Details | |
| 2023-03-14 23:11:25 -0500 | Rating Details | |
| 2023-03-06 07:47:34 -0600 | Rating Details | |
| 2023-03-06 01:17:07 -0600 | Rating Details | |
| 2023-03-06 06:34:57 -0600 | Rating Details | |
| 2023-03-06 02:43:01 -0600 | Rating Details | |
| 2023-03-06 04:43:58 -0600 | Rating Details | |
| 2023-03-16 11:46:33 -0500 | Rating Details | |
| 2023-03-06 01:17:06 -0600 | Rating Details | |
| 2023-03-14 02:29:24 -0500 | Rating Details | |
| 2023-03-06 12:42:48 -0600 | Rating Details | |
| 2023-03-17 09:15:04 -0500 | Rating Details | |
| 2023-03-06 02:24:26 -0600 | Rating Details | |
| 2023-03-06 16:39:48 -0600 | Rating Details | |
| 2023-03-06 08:56:04 -0600 | Rating Details | |
| 2023-03-06 04:36:45 -0600 | Rating Details | |
| 2023-03-06 20:43:50 -0600 | Rating Details | |
| 2023-03-06 10:57:27 -0600 | Rating Details | |
| 2023-03-08 08:26:26 -0600 | Rating Details | |
| 2023-03-06 03:15:58 -0600 | Rating Details | |
| 2023-03-14 23:37:13 -0500 | Rating Details | |
| 2023-03-06 02:29:17 -0600 | Rating Details | |
| 2023-03-06 01:17:10 -0600 | Rating Details | |
| 2023-03-06 02:27:03 -0600 | Rating Details |